Boyka Stoykova

1.3k total citations
23 papers, 969 citations indexed

About

Boyka Stoykova is a scholar working on Economics and Econometrics, General Health Professions and Epidemiology. According to data from OpenAlex, Boyka Stoykova has authored 23 papers receiving a total of 969 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Economics and Econometrics, 7 papers in General Health Professions and 4 papers in Epidemiology. Recurrent topics in Boyka Stoykova's work include Health Systems, Economic Evaluations, Quality of Life (9 papers), Healthcare Policy and Management (6 papers) and Healthcare cost, quality, practices (4 papers). Boyka Stoykova is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (9 papers), Healthcare Policy and Management (6 papers) and Healthcare cost, quality, practices (4 papers). Boyka Stoykova collaborates with scholars based in United Kingdom, United States and Italy. Boyka Stoykova's co-authors include Michael Drummond, Robin Dowie, Julie Glanville, John Nixon, Maribel Almonte, Clare Gilham, Alexandra Sargent, Julian Peto, Kate Misso and Christiane Hoffmann and has published in prestigious journals such as Journal of Clinical Oncology, The Lancet Oncology and European Heart Journal.

In The Last Decade

Boyka Stoykova

22 papers receiving 932 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Boyka Stoykova United Kingdom 12 445 217 205 193 175 23 969
Zuleika Saz‐Parkinson Spain 16 232 0.5× 84 0.4× 101 0.5× 178 0.9× 250 1.4× 45 879
Ami Vyas United States 17 153 0.3× 190 0.9× 242 1.2× 78 0.4× 187 1.1× 66 864
Leila Allahqoli Iran 18 219 0.5× 45 0.2× 203 1.0× 54 0.3× 338 1.9× 119 1.2k
Arya Aminorroaya United States 19 155 0.3× 37 0.2× 167 0.8× 95 0.5× 113 0.6× 77 916
Muqing Yu China 7 193 0.4× 40 0.2× 88 0.4× 52 0.3× 386 2.2× 11 1.7k
Jianing Li China 20 393 0.9× 22 0.1× 161 0.8× 43 0.2× 171 1.0× 67 1.0k
Kathleen Decker Canada 17 192 0.4× 73 0.3× 83 0.4× 114 0.6× 677 3.9× 77 989
Shaheen Kurani United States 11 157 0.4× 50 0.2× 68 0.3× 155 0.8× 139 0.8× 24 702
Kathy L. MacLaughlin United States 16 309 0.7× 21 0.1× 93 0.5× 100 0.5× 205 1.2× 50 843

Countries citing papers authored by Boyka Stoykova

Since Specialization
Citations

This map shows the geographic impact of Boyka Stoykova's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Boyka Stoykova with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Boyka Stoykova more than expected).

Fields of papers citing papers by Boyka Stoykova

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Boyka Stoykova. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Boyka Stoykova. The network helps show where Boyka Stoykova may publish in the future.

Co-authorship network of co-authors of Boyka Stoykova

This figure shows the co-authorship network connecting the top 25 collaborators of Boyka Stoykova. A scholar is included among the top collaborators of Boyka Stoykova based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Boyka Stoykova. Boyka Stoykova is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
English, Marci, Boyka Stoykova, Christina Slota, et al.. (2021). Qualitative study: burden of menopause-associated vasomotor symptoms (VMS) and validation of PROMIS Sleep Disturbance and Sleep-Related Impairment measures for assessment of VMS impact on sleep. Journal of Patient-Reported Outcomes. 5(1). 37–37. 33 indexed citations
2.
3.
Almonte, Maribel, Clare Gilham, Robin Dowie, et al.. (2009). ARTISTIC: a randomised trial of human papillomavirus (HPV) testing in primary cervical screening. Health Technology Assessment. 13(51). 1–150, iii. 149 indexed citations
4.
Kitchener, Henry C, Maribel Almonte, Claire Thomson, et al.. (2009). HPV testing in combination with liquid-based cytology in primary cervical screening (ARTISTIC): a randomised controlled trial. The Lancet Oncology. 10(7). 672–682. 290 indexed citations
5.
Stoykova, Boyka, et al.. (2009). PIN57 A COMPARISON OF THE COST-EFFECTIVENESS OF THE 13-VALENT (PCVI3) AND 10-VALENT PNEUMOCOCCAL CONJUGATE VACCINES IN THE UK. Value in Health. 12(7). A428–A428. 4 indexed citations
6.
7.
Stoykova, Boyka, Georgi Kuzmanov, & Robin Dowie. (2008). Putting National Institute for Health and Clinical Excellence guidance into practice: A cost minimization model of a national roll-out of liquid based cytology in England. International Journal of Technology Assessment in Health Care. 24(4). 391–398. 3 indexed citations
8.
Sabharwal, Nikant, Boyka Stoykova, Anil Taneja, & Avijit Lahiri. (2007). A randomized trial of exercise treadmill ECG versus stress SPECT myocardial perfusion imaging as an initial diagnostic strategy in stable patients with chest pain and suspected CAD: Cost analysis. Journal of Nuclear Cardiology. 14(2). 174–186. 27 indexed citations
9.
10.
Dowie, Robin, Boyka Stoykova, & M. Desai. (2006). Assessing the wellbeing of cytoscreeners: experience in two NHS cytology laboratories. Cytopathology. 17(6). 366–373. 4 indexed citations
11.
12.
Stoykova, Boyka. (2004). Ambulance emergency services for patients with coronary heart disease in Lancashire: achieving standards and improving performance. Emergency Medicine Journal. 21(1). 99–104. 6 indexed citations
13.
Stoykova, Boyka, Robin Dowie, & HC Kitchener. (2004). Assessing economics of treatments for gynecological cancer where clinical effectiveness meets value for money. International Journal of Gynecological Cancer. 14(5). 762–771. 1 indexed citations
14.
Stoykova, Boyka, Robin Dowie, R. P. F. Gregory, Kathleen V. Rowsell, & Stephen J. Lane. (2004). “Event tree” approach for facilitating audit of ambulance cardiac services. Clinical Governance An International Journal. 9(2). 115–122. 3 indexed citations
15.
Stoykova, Boyka, Robin Dowie, & HC Kitchener. (2004). Assessing economics of treatments for gynecological cancer where clinical effectiveness meets value for money. International Journal of Gynecological Cancer. 14(5). 762–771. 1 indexed citations
16.
Stoykova, Boyka, Michael Drummond, Marco Barbieri, & Jos Kleijnen. (2003). The lag between effectiveness and cost-effectiveness evidence of new drugs. The European Journal of Health Economics. 4(4). 313–318. 16 indexed citations
17.
Hoffmann, Christiane, Boyka Stoykova, John Nixon, et al.. (2002). Re: Hutton J, Brown R. Use of economic evaluation in decision-making: what needs to change? (Editorial) Value Health 2002;5:65-6.. PubMed. 5(2). 114–114. 101 indexed citations
18.
Hoffmann, Christiane, Boyka Stoykova, John Nixon, et al.. (2002). Do Health-Care Decision Makers Find Economic Evaluations Useful? The Findings of Focus Group Research in UK Health Authorities. Value in Health. 5(2). 71–78. 93 indexed citations
19.
Nixon, John, et al.. (2000). The U.K. NHS ECONOMIC EVALUATION DATABASE. International Journal of Technology Assessment in Health Care. 16(3). 731–742. 38 indexed citations
20.
Nixon, Jane, et al.. (2000). Infopoints: NHS Economic Evaluation Database for healthcare decision makers. BMJ. 321(7252). 32–32. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zuleika Saz‐Parkinson Breakdown of academic impact, for papers by Ami Vyas Breakdown of academic impact, for papers by Leila Allahqoli Breakdown of academic impact, for papers by Arya Aminorroaya Breakdown of academic impact, for papers by Muqing Yu Breakdown of academic impact, for papers by Jianing Li Breakdown of academic impact, for papers by Kathleen Decker Breakdown of academic impact, for papers by Shaheen Kurani Breakdown of academic impact, for papers by Kathy L. MacLaughlin
Rankless by CCL
2026